Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BiBo Pharma
Boston, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
BiBo Pharma operates multiple commercial-scale GMP manufacturing facilities for biologics, including proteins, peptides, cell and gene therapies, and antibody-drug conjugates, with participation in over 20 commercial-stage projects and at least three projects in phase III and commercialization. The company is an industry leader in ultra-large-scale manufacturing technologies and has achieved global quality accreditations from clients and regulatory bodies.
- Modalities
- ProteinPeptidesCell therapyGene therapyAntibody-drug conjugateMammalian cell cultureMicrobial fermentation
- Industry
- Contract Manufacturing Organization
02
Partnerships
89bioBoston Institute of Biotechnology
Beyond the preview
Go deeper on BiBo Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BiBo Pharma.